MANCHESTER, N.H.--(BUSINESS WIRE)--May is National Arthritis Awareness month, an occasion to highlight a disease that affects over 50 million Americans and is the number one cause of disability in the U.S.1 During this observation, it is important to consider advances in treatment options, as a multitude of studies have surfaced that suggest traditional remedies may not be as safe or effective as once assumed--shedding light on some newer options that could help relieve joint discomfort for millions.
Given the FDA’s urgent priority on non-pharmacologic approaches to pain treatment2, treating joint discomfort now has a new dimension. Findings suggest that some common prescriptions and over the counter remedies could be ineffective or dangerous:
- The Lancet published studies that show for older patients, acetaminophen provides no more osteoarthritis pain relief and improvement in function than a placebo.3
- According to the American College of Rheumatology, popular supplements to treat osteoarthritis, glucosamine and chondroitin, show modest to no improvement compared to placebo in pain relief or joint damage.4
- In a recent study published by The New England Journal of Medicine, the FDA called finding non-pharmacologic approaches to pain treatment an urgent priority--citing the epidemic of opiate abuse.5
- According to the Arthritis Foundation, popular nonsteroidal anti-inflammatory drugs (NSAIDs) such as aspirin and ibuprofen are options for arthritis pain relief, but serious risks can include ulcers, bleeding, heart attack, stroke, and kidney damage. The Osteoarthritis Research Society International (OARSI) recommends that people at high risk for side effects like cardiovascular disease or GI bleeding should avoid using NSAIDs entirely. 6
- GOPO® Rosehip with Galactolipids, the UK’s #3 rated joint care supplement is the only product of its kind to contain a high level of GOPO--a key component of the rose-hip. In a clinical study conducted at the University of Copenhagen in Denmark, GOPO was shown to help reduce joint pain and stiffness in up to 82% of people.7*
Jonathan Groves, Jakemans, Inc. president said, “With 1 in 5 adults and 300,000 children affected by arthritis and joint pain, there is a huge need for additional remedies for these conditions. Doctors and patients are seeking safer and healthier alternatives to relieve joint pain. Given the new research and guidelines on over the counter medications and the dangers of opioid use, those who suffer from joint and arthritis pain should consider GOPO® Rosehip with Galactolipids as a natural alternative for relief--and it’s backed by numerous research studies.”
Laboratory studies have shown that GOPO can switch off certain genes responsible for producing proteins and enzymes that have been implicated in inflammatory joint destruction and switch on genes that help to produce collagen and cartilage, which are essential components of a healthy joint.*
GOPO® Rosehip with Galactolipids is the only product of its kind to contain a high level of GOPO--a key component of the rosehip, which may play a valuable role in the care of joints and joint tissues.*
GOPO® has been evaluated in numerous rigorously-conducted, placebo-controlled, clinical trials involving hundreds of patients with difficult-to-treat chronic joint conditions including osteoarthritis and rheumatoid arthritis. Efficacy results have been consistently positive and evidence supporting the benefits of GOPO® has been presented around the world at numerous clinical meetings and many studies have been published in peer-reviewed journals.*
For more information about GOPO® Rosehip with Galactolipids, please visit www.gopo.us.
About Jakemans, Inc.
Jakemans, Inc., is the US subsidiary of G.R. Lane Health Products Ltd. Lanes is one of the major natural medicine companies in the UK. Lanes manufactures and markets well-known products such as Olbas®, Kalms, Quiet Life, and Jakemans® Throat & Chest™ Lozenges.
Established in the 1930s by Gilbert Lane – an early supporter of the idea that we can improve our health through diet and the use of carefully selected plants and nutrients – Lanes remains a family owned business and is chaired by Gilbert’s granddaughter, Janet Lane.
1 Centers for Disease Control and Prevention. Addressing the nation’s most common form of disability, 2015.
2 New England Journal of Medicine. Feb 4, 2016. A proactive response to prescription opioid abuse.
3 The Lancet: Bruno R da Costa, PhD, Stephan Reichenbach, MD, Noah Keller, MMed, Linda Nartey, MD, Simon Wandel, PhD, Prof Peter Jüni, MD, Dr Sven Trelle, MD, Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis. http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(16)30002-2/abstract
4 American College of Rheumatology. 2012 Recommendations for the Use of Nonpharmacological and Pharmacologic Therapies in Osteoarthritis of the Hand, Hip, and Knee. Arthritis Care Res (Hoboken). 2012 Apr; 64(4):465-74. Review.
5 The New England Journal of Medicine. Feb 4, 2016. A proactive response to prescription opioid abuse.
6 The Arthritis Foundation. Feb 22, 2016. 25 Treatments for Hip and Knee Arthritis Pain.
7 Scandinavian Journal of Rheumatology (August 2005)
*These statements have not been evaluated by the Food & Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.